scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1471-4159.1996.67051897.X |
P698 | PubMed publication ID | 8863494 |
P2093 | author name string | S W Miller | |
W D Parker | |||
R E Davis | |||
P A Trimmer | |||
P4510 | describes a project that uses | SH-SY5Y Rho0 64/5 | Q54953224 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mitochondrial DNA | Q27075 |
cell line | Q21014462 | ||
P304 | page(s) | 1897-1907 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Creation and characterization of mitochondrial DNA-depleted cell lines with "neuronal-like" properties | |
P478 | volume | 67 |
Q40708696 | A newly established neuronal rho-0 cell line highly susceptible to oxidative stress accumulates iron and other metals. Relevance to the origin of metal ion deposits in brains with neurodegenerative disorders |
Q42487544 | Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells |
Q41457391 | Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells |
Q39143414 | Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines |
Q30470555 | Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. |
Q37219429 | Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics |
Q26859496 | Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies |
Q36813613 | Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence |
Q38413032 | Effect of cholinergic signaling on neuronal cell bioenergetics |
Q30471565 | Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease |
Q33944937 | Energetics in the pathogenesis of neurodegenerative diseases |
Q85895943 | Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells |
Q30513977 | Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. |
Q34184643 | Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype. |
Q37709664 | Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell |
Q39147261 | Involvement of reactive oxygen species derived from mitochondria in neuronal injury elicited by methylmercury |
Q34537479 | Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model |
Q41078616 | Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties |
Q47784287 | Mitochondria and Mitochondrial Cascades in Alzheimer's Disease |
Q34170717 | Mitochondria and Neuroplasticity |
Q30310386 | Mitochondria in Alzheimer's disease |
Q38932850 | Mitochondria, Cybrids, Aging, and Alzheimer's Disease |
Q30305575 | Mitochondrial DNA-depleted neuroblastoma (Rho degrees) cells exhibit altered calcium signaling |
Q48769729 | Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells |
Q39677617 | Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer's-Disease Related Pathology |
Q30304277 | Mitochondrial abnormalities in non-alcoholic steatohepatitis |
Q30446972 | Mitochondrial dysfunction in idiopathic Parkinson disease |
Q34837674 | Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells |
Q33540918 | Mitochondrial involvement in Alzheimer's disease |
Q38925765 | Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells |
Q30422362 | Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression |
Q30454431 | Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease |
Q53266394 | Oxidative stress level in circulating neutrophils is linked to neurodegenerative diseases. |
Q24562914 | Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics |
Q40970152 | Pulsatile shear stress leads to DNA fragmentation in human SH-SY5Y neuroblastoma cell line |
Q42474795 | Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells |
Q28391369 | Redox regulation of store-operated Ca2+ entry |
Q30439165 | Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy |
Q40868003 | Rhabdomyosarcoma rho(0) cells: isolation and characterization of a mitochondrial DNA depleted cell line with 'muscle-like' properties |
Q35958359 | Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases |
Q46839158 | The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease. |
Q46428440 | The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm |
Q36470441 | The creation of cybrids harboring mitochondrial haplogroups in the Taiwanese population of ethnic Chinese background: an extensive in vitro tool for the study of mitochondrial genomic variations |
Q39858276 | The isatin-Schiff base copper(II) complex Cu(isaepy)2 acts as delocalized lipophilic cation, yields widespread mitochondrial oxidative damage and induces AMP-activated protein kinase-dependent apoptosis |
Q36796270 | Transmitochondrial technology in animal cells |
Q73944617 | Transmitochondrial technology in animal cells |
Q40381773 | Two-dimensional electrophoresis and mass spectrometric identification of mitochondrial proteins from an SH-SY5Y neuroblastoma cell line |
Q58122630 | mtDNA Population Variants and Neurodegenerative Diseases |
Q54953224 | SH-SY5Y Rho0 64/5 | described by source | P1343 |
Search more.